Literature DB >> 21632452

When hope is all there is left.

Hanneke W M van Laarhoven1, Carlo J W Leget, Winette T A van der Graaf.   

Abstract

Mesh：

Year:  2011        PMID： 21632452      PMCID： PMC3228227          DOI： 10.1634/theoncologist.2010-0064

Source DB:  PubMed          Journal:  Oncologist        ISSN： 1083-7159


× No keyword cloud information.
  8 in total

1.  Necessary collusion: prognostic communication with advanced cancer patients.

Authors:  Paul R Helft
Journal:  J Clin Oncol       Date:  2005-05-01       Impact factor: 44.544

2.  Another infusion of hope.

Authors:  Francesca Giorgi; Romeo Bascioni
Journal:  J Clin Oncol       Date:  2009-01-26       Impact factor: 44.544

3.  Cancer and the family: the silent words of truth.

Authors:  Lea Baider; Antonella Surbone
Journal:  J Clin Oncol       Date:  2009-11-16       Impact factor: 44.544

4.  Complexities in prognostication in advanced cancer: "to help them live their lives the way they want to".

Authors:  Elizabeth B Lamont; Nicholas A Christakis
Journal:  JAMA       Date:  2003-07-02       Impact factor: 56.272

Review 5.  Improvement of informed consent and the quality of consent documents.

Authors:  Michael Jefford; Rosemary Moore
Journal:  Lancet Oncol       Date:  2008-05       Impact factor: 41.316

Review 6.  Sustaining hope when communicating with terminally ill patients and their families: a systematic review.

Authors:  Josephine M Clayton; Karen Hancock; Sharon Parker; Phyllis N Butow; Sharon Walder; Sue Carrick; David Currow; Davina Ghersi; Paul Glare; Rebecca Hagerty; Ian N Olver; Martin H N Tattersall
Journal:  Psychooncology       Date:  2008-07       Impact factor: 3.894

Review 7.  Hope.

Authors:  Richard T Penson; Fei Gu; Susan Harris; Mary Martha Thiel; Nat Lawton; Arlan F Fuller; Thomas J Lynch
Journal:  Oncologist       Date:  2007-09

8.  Information and participation preferences among cancer patients.

Authors:  B R Cassileth; R V Zupkis; K Sutton-Smith; V March
Journal:  Ann Intern Med       Date:  1980-06       Impact factor: 25.391
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.